GlassScriptPhysician profile
Timothy D Oliver
NPI 1861415705
$4,564.75
in general payments reported to CMS, 2019-2025
15 companies · $93.93 in 2025
The $93.93 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.97 · 2020: $13.19 · 2021: $23.72 · 2022: $302 · 2023: $46.73 · 2024: $4,000 · 2025: $93.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $4,000 · Food and Beverage: $141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $4,000.00 |
| Food and Beverage | $140.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,000.00 | 2024 | |
| Amgen INC. | $119.63 | 2022 | |
| Spr Therapeutics, INC | $93.93 | 2025 | Sprint Pns System |
| Corcept Therapeutics | $73.40 | 2019-2023 | Korlym |
| Pfizer INC. | $37.99 | 2022-2023 | |
| Amarin Pharma, INC. | $37.96 | 2019-2022 | |
| Novo Nordisk INC | $37.41 | 2021-2023 | Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $32.91 | 2022 | |
| Dexcom, INC. | $23.95 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.26 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.88 | 2022 | |
| Abbvie INC. | $19.16 | 2022 | |
| Sanofi Pasteur INC. | $16.18 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $15.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.